Literature DB >> 8585730

Biogenesis of the mycobacterial cell wall and the site of action of ethambutol.

K Mikusová1, R A Slayden, G S Besra, P J Brennan.   

Abstract

The effect of ethambutol (EMB) is primarily on polymerization steps in the biosynthesis of the arabinan component of cell wall arabinogalactan (AG) of Mycobacterium smegmatis. Inhibition of the synthesis of the arabinan of lipoarabinomannan (LAM) occurred later, and thus in the cases of AG and LAM, the polymerization of D-arabinofuranose apparently involves separate pathways. While the synthesis of these arabinans was normal in an EMB-resistant isogeneic strain, the addition of EMB to the resistant strain resulted in partial inhibition of the synthesis of the arabinan of LAM and the emergence of a novel, truncated form of LAM, indicating partial susceptibility of the resistant gene(s) and providing a new intermediate in the LAM biosynthetic sequence. A consequence of inhibition of AG arabinan biosynthesis is the lack of new sites for mycolate attachment and thus the channeling of mycolate residues into a variety of free lipids which then accumulate. The primary biochemical effects of EMB can be explained by postulating separate AG and LAM pathways catalyzed by a variety of extramembranous arabinosyl transferases with various degrees of sensitivity to EMB.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8585730      PMCID: PMC162969          DOI: 10.1128/AAC.39.11.2484

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

2.  Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis.

Authors:  K Takayama; J O Kilburn
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 3.  Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some thoughts and possibilities arising from recent structural information.

Authors:  M R McNeil; P J Brennan
Journal:  Res Microbiol       Date:  1991-05       Impact factor: 3.992

4.  The 7H11 medium for the cultivation of mycobacteria.

Authors:  M L Cohn; R F Waggoner; J K McClatchy
Journal:  Am Rev Respir Dis       Date:  1968-08

Review 5.  The mycobacterial cell wall.

Authors:  E Lederer
Journal:  Pure Appl Chem       Date:  1971       Impact factor: 2.453

6.  Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains.

Authors:  D Chatterjee; K Lowell; B Rivoire; M R McNeil; P J Brennan
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

7.  Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis.

Authors:  S B Snapper; R E Melton; S Mustafa; T Kieser; W R Jacobs
Journal:  Mol Microbiol       Date:  1990-11       Impact factor: 3.501

8.  Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug.

Authors:  G Silve; P Valero-Guillen; A Quemard; M A Dupont; M Daffe; G Laneelle
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

9.  Stimulation of mycolic acid biosynthesis by incorporation of cis-tetracos-5-enoic acid in a cell-wall preparation from Mycobacterium smegmatis.

Authors:  P R Wheeler; G S Besra; D E Minnikin; C Ratledge
Journal:  Biochim Biophys Acta       Date:  1993-04-07

10.  Structural features of the arabinan component of the lipoarabinomannan of Mycobacterium tuberculosis.

Authors:  D Chatterjee; C M Bozic; M McNeil; P J Brennan
Journal:  J Biol Chem       Date:  1991-05-25       Impact factor: 5.157

View more
  77 in total

Review 1.  Nanoparticle delivery of anti-tuberculosis chemotherapy as a potential mediator against drug-resistant tuberculosis.

Authors:  Jonathan Paul Smith
Journal:  Yale J Biol Med       Date:  2011-12

Review 2.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations.

Authors:  S Sreevatsan; K E Stockbauer; X Pan; B N Kreiswirth; S L Moghazeh; W R Jacobs; A Telenti; J M Musser
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

4.  Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis.

Authors:  S V Ramaswamy; A G Amin; S Göksel; C E Stager; S J Dou; H El Sahly; S L Moghazeh; B N Kreiswirth; J M Musser
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

5.  Nucleotide polymorphism associated with ethambutol resistance in clinical isolates of Mycobacterium tuberculosis.

Authors:  S Srivastava; A Garg; A Ayyagari; K K Nyati; T N Dhole; S K Dwivedi
Journal:  Curr Microbiol       Date:  2006-09-12       Impact factor: 2.188

6.  Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis.

Authors:  Ann S G Lee; Siti Noor Khadijah Othman; Yu Min Ho; Sin Yew Wong
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

7.  Exposure of mycobacteria to cell wall-inhibitory drugs decreases production of arabinoglycerolipid related to Mycolyl-arabinogalactan-peptidoglycan metabolism.

Authors:  Yoann Rombouts; Belinda Brust; Anil K Ojha; Emmanuel Maes; Bernadette Coddeville; Elisabeth Elass-Rochard; Laurent Kremer; Yann Guerardel
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

Review 8.  Cure of tuberculosis using nanotechnology: An overview.

Authors:  Rout George Kerry; Sushanto Gouda; Bikram Sil; Gitishree Das; Han-Seung Shin; Gajanan Ghodake; Jayanta Kumar Patra
Journal:  J Microbiol       Date:  2018-05-02       Impact factor: 3.422

9.  Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.

Authors:  Vadim Makarov; Giulia Manina; Katarina Mikusova; Ute Möllmann; Olga Ryabova; Brigitte Saint-Joanis; Neeraj Dhar; Maria Rosalia Pasca; Silvia Buroni; Anna Paola Lucarelli; Anna Milano; Edda De Rossi; Martina Belanova; Adela Bobovska; Petronela Dianiskova; Jana Kordulakova; Claudia Sala; Elizabeth Fullam; Patricia Schneider; John D McKinney; Priscille Brodin; Thierry Christophe; Simon Waddell; Philip Butcher; Jakob Albrethsen; Ida Rosenkrands; Roland Brosch; Vrinda Nandi; Sowmya Bharath; Sheshagiri Gaonkar; Radha K Shandil; Venkataraman Balasubramanian; Tanjore Balganesh; Sandeep Tyagi; Jacques Grosset; Giovanna Riccardi; Stewart T Cole
Journal:  Science       Date:  2009-03-19       Impact factor: 47.728

10.  Carboxylate Surrogates Enhance the Antimycobacterial Activity of UDP-Galactopyranose Mutase Probes.

Authors:  Valerie J Winton; Claudia Aldrich; Laura L Kiessling
Journal:  ACS Infect Dis       Date:  2016-06-29       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.